US4374146A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Topical inflammatory pharmaceutical formulations
Assignee: SmithKline Beecham Corp
•
Filing: 1981-11-23
•
Granted: 1983-02-15
•
Expires: 2001-11-23
Abstract
Abstract A compound of the formula (I) may be prepared by known methods and may be used in the treatment of pain, inflammation or pyresis in mammals, by administration of the compound alone or in a pharmaceutical formulation suitable for administration to a mammal in need thereof. ##STR1##
Inventors
- 👤 Arthur P. Phillips
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 20:22
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/357; A61K31/36; C; C07; C07D; C07D317/00; C07D317/08; C07D317/44; C07D317/46; C07D317/48; C07D317/62; C07D317/66
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
40 words
A method for the treatment or prophylaxis of a condition selected from pain, inflammation and pyresis in a mammal comprising the administration to said mammal of a non-toxic, effective analgesic, anti-inflammatory or antipyretic amount of a compound of N-(1,3-benzodioxol-5-yl) acetamide.
Claim 2
Independent Claim
40 words
A method for the treatment or prophylaxis of a condition selected from pain, inflammation and pyresis in a mammal comprising the administration to said mammal of a non-toxic, effective analgesic, anti-inflammatory or antipyretic amount of a compound of N-(1,3-benzodioxol-5-yl) acetamide.
Claim 3
Independent Claim
49 words
A method for the treatment or prophylaxis of a condition selected from pain, inflammation and pyresis in a mammal comprising the administration to said mammal of a non-toxic, effective analgesic, anti-inflammatory or anti-pyretic amount of a pharmaceutical formulation containing the compound N-(1,3-benzodioxol-5-yl) acetamide and a pharmaceutically acceptable carrier therefor.
Claim 4
Independent Claim
49 words
A method for the treatment or prophylaxis of a condition selected from pain, inflammation and pyresis in a mammal comprising the administration to said mammal of a non-toxic, effective analgesic, anti-inflammatory or anti-pyretic amount of a pharmaceutical formulation containing the compound N-(1,3-benzodioxol-5-yl) acetamide and a pharmaceutically acceptable carrier therefor.
Claim 5
Dependent Claim
26 words
A method according to claim 1 or 2 wherein the compound is administered in the range of from 1 to 100 mg/kg mammal bodyweight per day.
Claim 6
Dependent Claim
34 words
A method according to claim 1 or 2 wherein the compound of formula (I), as defined in claim 1, is administered in the range of from 0.5 to 30 mg/kg mammal bodyweight per dose.
Claim 7
Dependent Claim
30 words
A method according to claim 1 or 2 for the treatment or prophylaxis of a condition selected from headache, toothache, rheumatoid arthritis, osteoarthritis and pyresis associated with pain and inflammation.
Claim 8
Dependent Claim
14 words
The method of claim 1 or 2 in which the mammal is a human.
Claim 9
Dependent Claim
45 words
A pharmaceutical formulation for treatment or prophylaxis of a condition selected from pain, inflammation and pyresis comprising an effective amount of the compound N-(1,3-benzodioxol-5-yl) acetamide in association with a pharmaceutically acceptable carrier, said formulation in the form of a tablet, capsule, syrup, lozenge or suppository.
Claim 10
Dependent Claim
45 words
A pharmaceutical formulation for treatment or prophylaxis of a condition selected from pain, inflammation and pyresis comprising an effective amount of the compound N-(1,3-benzodioxol-5-yl) acetamide in association with a pharmaceutically acceptable carrier, said formulation in the form of a tablet, capsule, syrup, lozenge or suppository.
Claim 11
Dependent Claim
41 words
A pharmaceutical formulation for treatment or prophylaxis of a condition selected from pain, inflammation and pyresis comprising an effective amount of the compound N-(1,3-benzodioxol-5-yl) acetamide in association with a pharmaceutically acceptable sterile carrier, said formulation in a form for parenteral administration.
Claim 12
Dependent Claim
41 words
A pharmaceutical formulation for treatment or prophylaxis of a condition selected from pain, inflammation and pyresis comprising an effective amount of the compound N-(1,3-benzodioxol-5-yl) acetamide in association with a pharmaceutically acceptable sterile carrier, said formulation in a form for parenteral administration.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-02-14 | 1986-08-16 | 1987-02-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-02-14 | 1990-08-16 | 1991-02-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-02-14 | 1994-08-16 | 1995-02-15 | $7700.00 | Window Closed / Lapsed |